将GWAS转化为临床实践:糖尿病风险分层的多基因风险评分的实际应用

IF 6.3 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY
Inhwa Jeong
{"title":"将GWAS转化为临床实践:糖尿病风险分层的多基因风险评分的实际应用","authors":"Inhwa Jeong","doi":"10.1093/clinchem/hvaf086.613","DOIUrl":null,"url":null,"abstract":"Background Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder which arises from a complex interplay of genetic, environmental and behavioral factors. We evaluated the clinical utility of polygenic risk score (PRS)-based multigene panel test for predicting diabetes mellitus (DM) in a healthy population. Methods Overall, 302 individuals underwent genetic testing using the HelloGene™ DM panel, which comprises four DM-related SNPs (CDKAL1, HHEX, KCNQ1, TCF7L2). Each genotype was analyzed using a PRS algorithm based on a dataset of 70,000 Koreans, classifying participants into four risk groups (low, moderate, high, and very high). Fasting blood glucose (FBG), glycated hemoglobin (HbA1c), and body mass index were measured at baseline and after at least 3 years of follow-up. Smoking status, alcohol use, and exercise status were recorded. Results No significant differences in age, sex, or lifestyle habits were observed among the PRS groups. The ‘very high risk’ group had significantly higher 3-year follow-up FBG (p=0.001) and baseline/3-year follow-up HbA1c (p=0.025 and 0.001, respectively) levels (Table 1). The ‘very high risk’ group had a 4.5-fold higher risk of developing DM compared to other groups (Table 2A). Smoking was a significant modifier of genetic risk; smokers in the ‘very high-risk’ group had a 25% greater likelihood of developing DM. CDKAL1, HHEX, and TCF7L2 genotype carriers were prevalent in the individuals diagnosed with DM, while HHEX carriers in the ‘high risk’ group showed the greatest susceptibility, especially among current smokers (Table 2B). Conclusion PRS-based genetic testing demonstrated clinical utility in DM risk prediction. Elevated FBG and HbA1c levels in the high PRS group emphasize the importance of early identification. Smoking significantly increases genetic risk, underscoring the need for targeted interventions in genetically susceptible individuals.","PeriodicalId":10690,"journal":{"name":"Clinical chemistry","volume":"62 1","pages":""},"PeriodicalIF":6.3000,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"B-225 Translating GWAS into Clinical Practice: Real-World Utility of a Polygenic Risk Score for Diabetes Risk Stratification\",\"authors\":\"Inhwa Jeong\",\"doi\":\"10.1093/clinchem/hvaf086.613\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder which arises from a complex interplay of genetic, environmental and behavioral factors. We evaluated the clinical utility of polygenic risk score (PRS)-based multigene panel test for predicting diabetes mellitus (DM) in a healthy population. Methods Overall, 302 individuals underwent genetic testing using the HelloGene™ DM panel, which comprises four DM-related SNPs (CDKAL1, HHEX, KCNQ1, TCF7L2). Each genotype was analyzed using a PRS algorithm based on a dataset of 70,000 Koreans, classifying participants into four risk groups (low, moderate, high, and very high). Fasting blood glucose (FBG), glycated hemoglobin (HbA1c), and body mass index were measured at baseline and after at least 3 years of follow-up. Smoking status, alcohol use, and exercise status were recorded. Results No significant differences in age, sex, or lifestyle habits were observed among the PRS groups. The ‘very high risk’ group had significantly higher 3-year follow-up FBG (p=0.001) and baseline/3-year follow-up HbA1c (p=0.025 and 0.001, respectively) levels (Table 1). The ‘very high risk’ group had a 4.5-fold higher risk of developing DM compared to other groups (Table 2A). Smoking was a significant modifier of genetic risk; smokers in the ‘very high-risk’ group had a 25% greater likelihood of developing DM. CDKAL1, HHEX, and TCF7L2 genotype carriers were prevalent in the individuals diagnosed with DM, while HHEX carriers in the ‘high risk’ group showed the greatest susceptibility, especially among current smokers (Table 2B). Conclusion PRS-based genetic testing demonstrated clinical utility in DM risk prediction. Elevated FBG and HbA1c levels in the high PRS group emphasize the importance of early identification. Smoking significantly increases genetic risk, underscoring the need for targeted interventions in genetically susceptible individuals.\",\"PeriodicalId\":10690,\"journal\":{\"name\":\"Clinical chemistry\",\"volume\":\"62 1\",\"pages\":\"\"},\"PeriodicalIF\":6.3000,\"publicationDate\":\"2025-10-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/clinchem/hvaf086.613\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/clinchem/hvaf086.613","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

2型糖尿病(T2DM)是一种由遗传、环境和行为因素复杂相互作用引起的慢性代谢性疾病。我们评估了基于多基因风险评分(PRS)的多基因面板测试在健康人群中预测糖尿病(DM)的临床应用。总体而言,302人接受了HelloGene™糖尿病面板的基因检测,该面板包括4个DM相关snp (CDKAL1, HHEX, KCNQ1, TCF7L2)。每个基因型以7万名韩国人的数据为基础,通过PRS算法进行分析,将参与者分为4个风险组(低、中、高、高)。在基线和至少3年随访后测量空腹血糖(FBG)、糖化血红蛋白(HbA1c)和体重指数。记录吸烟状况、饮酒状况和运动状况。结果PRS组在年龄、性别、生活习惯等方面无显著差异。“非常高风险”组的3年随访FBG (p=0.001)和基线/3年随访HbA1c (p分别=0.025和0.001)水平显著较高(表1)。“非常高风险”组患糖尿病的风险是其他组的4.5倍(表2A)。吸烟是遗传风险的重要改变因素;“非常高风险”组的吸烟者患糖尿病的可能性高出25%。CDKAL1、HHEX和TCF7L2基因型携带者在诊断为糖尿病的个体中普遍存在,而“高风险”组的HHEX携带者表现出最大的易感性,特别是在当前吸烟者中(表2B)。结论基于prs的基因检测在糖尿病风险预测中具有临床应用价值。高PRS组中FBG和HbA1c水平升高强调了早期识别的重要性。吸烟显著增加遗传风险,强调需要对遗传易感个体进行有针对性的干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
B-225 Translating GWAS into Clinical Practice: Real-World Utility of a Polygenic Risk Score for Diabetes Risk Stratification
Background Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder which arises from a complex interplay of genetic, environmental and behavioral factors. We evaluated the clinical utility of polygenic risk score (PRS)-based multigene panel test for predicting diabetes mellitus (DM) in a healthy population. Methods Overall, 302 individuals underwent genetic testing using the HelloGene™ DM panel, which comprises four DM-related SNPs (CDKAL1, HHEX, KCNQ1, TCF7L2). Each genotype was analyzed using a PRS algorithm based on a dataset of 70,000 Koreans, classifying participants into four risk groups (low, moderate, high, and very high). Fasting blood glucose (FBG), glycated hemoglobin (HbA1c), and body mass index were measured at baseline and after at least 3 years of follow-up. Smoking status, alcohol use, and exercise status were recorded. Results No significant differences in age, sex, or lifestyle habits were observed among the PRS groups. The ‘very high risk’ group had significantly higher 3-year follow-up FBG (p=0.001) and baseline/3-year follow-up HbA1c (p=0.025 and 0.001, respectively) levels (Table 1). The ‘very high risk’ group had a 4.5-fold higher risk of developing DM compared to other groups (Table 2A). Smoking was a significant modifier of genetic risk; smokers in the ‘very high-risk’ group had a 25% greater likelihood of developing DM. CDKAL1, HHEX, and TCF7L2 genotype carriers were prevalent in the individuals diagnosed with DM, while HHEX carriers in the ‘high risk’ group showed the greatest susceptibility, especially among current smokers (Table 2B). Conclusion PRS-based genetic testing demonstrated clinical utility in DM risk prediction. Elevated FBG and HbA1c levels in the high PRS group emphasize the importance of early identification. Smoking significantly increases genetic risk, underscoring the need for targeted interventions in genetically susceptible individuals.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical chemistry
Clinical chemistry 医学-医学实验技术
CiteScore
11.30
自引率
4.30%
发文量
212
审稿时长
1.7 months
期刊介绍: Clinical Chemistry is a peer-reviewed scientific journal that is the premier publication for the science and practice of clinical laboratory medicine. It was established in 1955 and is associated with the Association for Diagnostics & Laboratory Medicine (ADLM). The journal focuses on laboratory diagnosis and management of patients, and has expanded to include other clinical laboratory disciplines such as genomics, hematology, microbiology, and toxicology. It also publishes articles relevant to clinical specialties including cardiology, endocrinology, gastroenterology, genetics, immunology, infectious diseases, maternal-fetal medicine, neurology, nutrition, oncology, and pediatrics. In addition to original research, editorials, and reviews, Clinical Chemistry features recurring sections such as clinical case studies, perspectives, podcasts, and Q&A articles. It has the highest impact factor among journals of clinical chemistry, laboratory medicine, pathology, analytical chemistry, transfusion medicine, and clinical microbiology. The journal is indexed in databases such as MEDLINE and Web of Science.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信